These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27562312)

  • 1. Equity, barriers and cancer disparities: study of the Spanish Society of Medical Oncology on the access to oncologic drugs in the Spanish Regions.
    Salvador J; Aparicio J; Baron FJ; Garcia-Campelo R; Garcia-Carbonero R; Lianes P; Llombart A; Isla D; Piera JM; Munoz M; Puente J; Rivera F; Rodriguez CA; Virizuela JA; Martin M; Garrido P
    Clin Transl Oncol; 2017 Mar; 19(3):341-356. PubMed ID: 27562312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of the Spanish Society of Medical Oncology (SEOM) on the access to oncology drugs and predictive biomarkers in Spain.
    Rodríguez-Lescure A; de la Peña FA; Aranda E; Calvo A; Felip E; Garrido P; Vera R
    Clin Transl Oncol; 2020 Dec; 22(12):2253-2263. PubMed ID: 32533318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geriatric oncology in Spain: survey results and analysis of the current situation.
    Gironés R; Morilla I; Guillen-Ponce C; Torregrosa MD; Paredero I; Bustamante E; Del Barco S; Soler G; Losada B; Visa L; Llabrés E; Fox B; Firvida JL; Blanco R; Antonio M; Aparisi F; Pi-Figueras M; Gonzalez-Flores E; Molina-Garrido MJ; Saldaña J;
    Clin Transl Oncol; 2018 Aug; 20(8):1087-1092. PubMed ID: 29327240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the availability of new anti-cancer drugs for Italian patients treated in different regions. Results of analysis conducted by the Italian Society Of Medical Oncology (AIOM).
    Gori S; Di Maio M; Pinto C; Alabiso O; Baldini E; Beretta GD; Caffo O; Caroti C; Crinò L; De Laurentiis M; Dinota A; Di Vito F; Gebbia V; Giustini L; Graiff C; Guida M; Lelli G; Lombardo M; Muggiano A; Puglisi F; Romito S; Salvagno L; Tagliaferri P; Terzoli E; Venturini M;
    Tumori; 2010; 96(6):1010-5. PubMed ID: 21388067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of cancer with oral drugs: a position statement by the Spanish Society of Medical Oncology (SEOM).
    Colomer R; Alba E; González-Martin A; Paz-Ares L; Martín M; Llombart A; Rodríguez Lescure Á; Salvador J; Albanell J; Isla D; Lomas M; Rodríguez CA; Trigo JM; Germà JR; Bellmunt J; Tabernero J; Rosell R; Aranda E; Cubedo R; Baselga J;
    Ann Oncol; 2010 Feb; 21(2):195-198. PubMed ID: 20110291
    [No Abstract]   [Full Text] [Related]  

  • 6. Recommendations by the Spanish Society of Hospital Pharmacy, the Spanish Society of Oncology Nursing and the Spanish Society of Medical Oncology for the safe management of antineoplastic medication in cancer patients.
    Vera R; Otero MJ; Ayala de la Peña F; González-Pérez C; Peñuelas Á; Sepúlveda JM; Quer N; Doménech-Climent N; Virizuela JA; Beorlegui P; Gorgas MQ
    Clin Transl Oncol; 2019 Apr; 21(4):467-478. PubMed ID: 30298467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations by the Spanish Society of Hospital Pharmacy, the Spanish Society of Oncology Nursing and the Spanish Society of Medical Oncology for the safe management of antineoplastic medication in cancer patients.
    Otero MJ; Vera R; González-Pérez C; Ayala de la Peña F; Peñuelas Á; Quer N
    Farm Hosp; 2018 Nov; 42(6):261-268. PubMed ID: 30381047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender influence on work satisfaction and leadership for medical oncologists: a survey of the Spanish Society of Medical Oncology (SEOM).
    Elez E; Ayala F; Felip E; García Campelo R; García Carbonero R; García Donás J; González Del Alba A; González Flores E; Hidalgo J; Isla D; Majem M; Rodríguez Lescure Á; Safont MJ; Santaballa A; Villacampa G; Vera R; Garrido P
    ESMO Open; 2021 Apr; 6(2):100048. PubMed ID: 33556897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of oral chemotherapy in outpatient clinics in Spain: results from a survey of the Spanish Society of Medical Oncology (SEOM).
    Santaballa A; De Castro J; Maurel J; Lázaro M; Vera R; Alba E
    Clin Transl Oncol; 2019 Apr; 21(4):534-538. PubMed ID: 30327937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erratum to: Equity, barriers and cancer disparities: study of the Spanish Society of Medical Oncology on the access to oncologic drugs in the Spanish Regions.
    Salvador J; Aparicio J; Baron FJ; García-Campelo R; Garcia-Carbonero R; Lianes P; Llombart A; Isla D; Piera JM; Muñoz M; Puente J; Rivera F; Rodríguez CA; Virizuela JA; Martín M; Garrido P
    Clin Transl Oncol; 2017 Apr; 19(4):525. PubMed ID: 28243989
    [No Abstract]   [Full Text] [Related]  

  • 11. Oncologist's knowledge and implementation of guidelines for breakthrough cancer pain in Spain: CONOCE study.
    López López R; Camps Herrero C; Khosravi-Shahi P; Guillem Porta V; Carrato Mena A; Garcia-Foncillas J; Cruz Hernández JJ; Gascón Vilaplana P; Antón Torres A; Diaz-Rubio E; Feyjoo Saus M; Aranda Aguilar E
    Clin Transl Oncol; 2018 May; 20(5):613-618. PubMed ID: 28975575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A definition for aggressive disease in patients with HER-2 negative metastatic breast cancer: an expert consensus of the Spanish Society of Medical Oncology (SEOM).
    González A; Lluch A; Aba E; Albanell J; Antón A; Álvarez I; Ayala F; Barnadas A; Calvo L; Ciruelos E; Cortés J; de la Haba J; López-Vega JM; Martínez E; Muñoz M; Peláez I; Redondo A; Rodríguez Á; Rodríguez CA; Ruíz A; Llombart A
    Clin Transl Oncol; 2017 May; 19(5):616-624. PubMed ID: 27853985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
    Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
    J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. American society of clinical oncology policy statement: disparities in cancer care.
    Goss E; Lopez AM; Brown CL; Wollins DS; Brawley OW; Raghavan D
    J Clin Oncol; 2009 Jun; 27(17):2881-5. PubMed ID: 19403885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disparity in the "time to patient access" to new anti-cancer drugs in Italian regions. Results of a survey conducted by the Italian Society of Medical Oncology (AIOM).
    Gori S; Di Maio M; Pinto C; Alabiso O; Baldini E; Barbato E; Beretta GD; Bravi S; Caffo O; Canobbio L; Carrozza F; Cinieri S; Cruciani G; Dinota A; Gebbia V; Giustini L; Graiff C; Molino A; Muggiano A; Pandoli G; Puglisi F; Tagliaferri P; Tomao S; Venturini M;
    Tumori; 2011; 97(4):442-8. PubMed ID: 21989431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TESEO, cancer-associated thrombosis registry from the Spanish Society of Medical Oncology (SEOM).
    Muñoz Martín AJ; Jiménez-Fonseca P; Carmona-Bayonas A; Martínez de Castro E; Muñoz Langa J; Pérez Segura P; Rodríguez Lescure A; Vera García R;
    Clin Transl Oncol; 2020 Aug; 22(8):1423-1424. PubMed ID: 31873915
    [No Abstract]   [Full Text] [Related]  

  • 17. Perspectives on Cost and Value in Cancer Care.
    Saltz LB
    JAMA Oncol; 2016 Jan; 2(1):19-21. PubMed ID: 26501848
    [No Abstract]   [Full Text] [Related]  

  • 18. Differences in cancer drug assessment between Spain and the United Kingdom.
    Lozano-Blázquez A; Dickson R; Fraga-Fuentes MD; Martínez-Martínez F; Calleja-Hernández MÁ
    Eur J Cancer; 2015 Sep; 51(13):1843-52. PubMed ID: 26119375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical oncology future plan of the Spanish Society of Medical Oncology: challenges and future needs of the Spanish oncologists.
    Rivera F; Andres R; Felip E; Garcia-Campelo R; Lianes P; Llombart A; Piera JM; Puente J; Rodriguez CA; Vera R; Virizuela JA; Martin M; Garrido P
    Clin Transl Oncol; 2017 Apr; 19(4):508-518. PubMed ID: 28005259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Geographic Access to Cancer Care, Insurance, and Receipt of Chemotherapy: Geographic Distribution of Oncologists and Travel Distance.
    Lin CC; Bruinooge SS; Kirkwood MK; Olsen C; Jemal A; Bajorin D; Giordano SH; Goldstein M; Guadagnolo BA; Kosty M; Hopkins S; Yu JB; Arnone A; Hanley A; Stevens S; Hershman DL
    J Clin Oncol; 2015 Oct; 33(28):3177-85. PubMed ID: 26304878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.